Nanogroup Valuation Multiples

Nanogroup Overview

About Nanogroup

Nanogroup SA develops biotechnological and medical projects for diagnostics, therapy and rehabilitation of oncological patients.

Founded

2013

HQ

Employees

46

Website

nanogroup.eu

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $1K

EBITDA: ($1M)

EV

$20M

Valuation Multiples

Multiples.vc

Start free trial

Nanogroup Financials

Nanogroup reported last fiscal year revenue of $1K and negative EBITDA of ($1M).

In the same fiscal year, Nanogroup generated ($12K) in gross profit, ($1M) in EBITDA losses, and had net loss of ($1M).

Nanogroup P&L

In the most recent fiscal year, Nanogroup reported revenue of $1K and EBITDA of ($1M).

Nanogroup expects next 12-month revenue of XXX and NTM EBITDA of XXX

Nanogroup Stock Performance

Nanogroup has current market cap of $23M, and enterprise value of $20M.

Nanogroup's stock price is $0.70.

Nanogroup Valuation Multiples

Nanogroup trades at 34303.2x EV/Revenue multiple, and (13.9x) EV/EBITDA.

Nanogroup Financial Valuation Multiples

As of April 19, 2026, Nanogroup has market cap of $23M and EV of $20M.

Equity research analysts estimate Nanogroup's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Nanogroup has a P/E ratio of (15.7x).

Nanogroup Margins & Growth Rates

Nanogroup's revenue in the last fiscal year grew by 4%.

Nanogroup's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Nanogroup Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Nanogroup M&A Activity

Nanogroup acquired XXX companies to date.

Last acquisition by Nanogroup was on XXXXXXXX, XXXXX. Nanogroup acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Nanogroup Investment Activity

Nanogroup invested in XXX companies to date.

Nanogroup made its latest investment on XXXXXXXX, XXXXX. Nanogroup invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).